AE Wealth Management LLC trimmed its stake in Teladoc Health, Inc. (NYSE:TDOC – Get Rating) by 5.9% in the 1st quarter, HoldingsChannel reports. The fund owned 14,328 shares of the health services provider’s stock after selling 904 shares during the quarter. AE Wealth Management LLC’s holdings in Teladoc Health were worth $1,033,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. CarsonAllaria Wealth Management Ltd. bought a new position in shares of Teladoc Health in the 4th quarter worth $30,000. City State Bank purchased a new position in Teladoc Health during the 4th quarter worth $27,000. Amplius Wealth Advisors LLC purchased a new position in Teladoc Health during the 4th quarter worth $38,000. Ellevest Inc. grew its stake in Teladoc Health by 133.0% during the 4th quarter. Ellevest Inc. now owns 445 shares of the health services provider’s stock worth $41,000 after buying an additional 254 shares during the last quarter. Finally, Standard Family Office LLC purchased a new position in Teladoc Health during the 4th quarter worth $41,000. 87.17% of the stock is owned by hedge funds and other institutional investors.
TDOC has been the topic of several research analyst reports. Royal Bank of Canada dropped their target price on Teladoc Health from $215.00 to $120.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 12th. Oppenheimer dropped their target price on Teladoc Health from $130.00 to $65.00 in a research note on Thursday, April 28th. Citigroup downgraded Teladoc Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $115.00 to $43.00 in a research note on Thursday, April 28th. Canaccord Genuity Group dropped their price target on Teladoc Health from $112.00 to $50.00 in a research note on Thursday, April 28th. Finally, Credit Suisse Group downgraded Teladoc Health from an “outperform” rating to a “neutral” rating and dropped their price target for the company from $114.00 to $35.00 in a research note on Thursday, April 28th. One equities research analyst has rated the stock with a sell rating, eighteen have assigned a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $85.82.
In other news, CFO Mala Murthy sold 4,053 shares of the company’s stock in a transaction that occurred on Monday, June 27th. The stock was sold at an average price of $37.32, for a total value of $151,257.96. Following the completion of the sale, the chief financial officer now directly owns 27,295 shares in the company, valued at $1,018,649.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Daniel Trencher sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, June 17th. The shares were sold at an average price of $29.12, for a total value of $29,120.00. Following the completion of the sale, the senior vice president now owns 28,408 shares of the company’s stock, valued at $827,240.96. The disclosure for this sale can be found here. 1.55% of the stock is owned by corporate insiders.
NYSE TDOC opened at $38.81 on Thursday. The stock has a market capitalization of $6.26 billion, a price-to-earnings ratio of -0.90 and a beta of 0.79. Teladoc Health, Inc. has a twelve month low of $27.38 and a twelve month high of $164.50. The company has a current ratio of 3.94, a quick ratio of 3.71 and a debt-to-equity ratio of 0.17. The stock has a 50-day moving average of $33.55 and a 200 day moving average of $59.24.
Teladoc Health (NYSE:TDOC – Get Rating) last released its quarterly earnings results on Wednesday, April 27th. The health services provider reported ($0.47) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.08. Teladoc Health had a negative return on equity of 2.12% and a negative net margin of 321.94%. The company had revenue of $565.35 million during the quarter, compared to analysts’ expectations of $568.91 million. During the same quarter in the prior year, the firm posted $0.13 EPS. Equities analysts predict that Teladoc Health, Inc. will post -2.05 EPS for the current fiscal year.
About Teladoc Health (Get Rating)
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
See Also
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Get Rating).
Receive News & Ratings for Teladoc Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Teladoc Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
